Search Results

There are 1423 results for: content related to: Comprehensive evaluation of hepatitis B virus reverse transcriptase substitutions associated with entecavir resistance

  1. Clonal evolution of multidrug resistant hepatitis B virus during entecavir rescue therapy

    Liver International

    Volume 35, Issue 11, November 2015, Pages: 2370–2383, Young E. Chon, Bora Jin, Sang H. Ahn, Seungtaek Kim, Nam D. Kim, Jeon H. Park, Chung M. Nam, Kyun-Hwan Kim, Sun P. Hong, Sung H. Choi, Do Y. Kim, Jun Y. Park and Kwang-Hyub Han

    Version of Record online : 13 MAY 2015, DOI: 10.1111/liv.12845

  2. Changes in viral loads of lamivudine-resistant mutants during entecavir therapy

    Hepatology Research

    Volume 38, Issue 2, February 2008, Pages: 132–140, Fumitaka Suzuki, Yoshiyuki Suzuki, Norio Akuta, Hiromi Yatsuji, Hitomi Sezaki, Yasuji Arase, Yusuke Kawamura, Tetsuya Hosaka, Masahiro Kobayashi, Kenji Ikeda, Mariko Kobayashi, Sachiyo Watahiki and Hiromitsu Kumada

    Version of Record online : 15 JUN 2007, DOI: 10.1111/j.1872-034X.2007.00144.x

  3. Multidrug-resistant hepatitis B virus resulting from sequential monotherapy with lamivudine, adefovir, and entecavir: Clonal evolution during lamivudine plus adefovir therapy

    Journal of Medical Virology

    Volume 85, Issue 1, January 2013, Pages: 55–64, Soon Sun Kim, Sung Won Cho, Soo-Ok Kim, Sun Pyo Hong and Jae Youn Cheong

    Version of Record online : 23 OCT 2012, DOI: 10.1002/jmv.23440

  4. You have free access to this content
    HBV Trials and Treatments

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 647A–705A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26856

  5. Spontaneous HBeAg seroconversion and loss of hepatitis B virus DNA after acute flare due to development of drug resistant mutants during entecavir monotherapy

    Hepatology Research

    Volume 39, Issue 1, January 2009, Pages: 14–20, Ri-Cheng Mao, You-Kuan Yin, Yan-Li Qin, Xiang-Hui Wu, Xin-Hua Weng, Ji-Ming Zhang and Mengji Lu

    Version of Record online : 3 OCT 2008, DOI: 10.1111/j.1872-034X.2008.00411.x

  6. You have free access to this content
    HBV Virology and Diagnostics

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 705A–730A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26857

  7. You have free access to this content
    Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy

    Hepatology

    Volume 49, Issue 5, May 2009, Pages: 1503–1514, Daniel J. Tenney, Ronald E. Rose, Carl J. Baldick, Kevin A. Pokornowski, Betsy J. Eggers, Jie Fang, Michael J. Wichroski, Dong Xu, Joanna Yang, Richard B. Wilber and Richard J. Colonno

    Version of Record online : 4 FEB 2009, DOI: 10.1002/hep.22841

  8. Impact of hepatitis B e antigen-suppressing mutations on the replication efficiency of entecavir-resistant hepatitis B virus strains

    Journal of Viral Hepatitis

    Volume 18, Issue 11, November 2011, Pages: 804–814, S. Amini-Bavil-Olyaee, U. Herbers, T. Luedde, C. Trautwein and F. Tacke

    Version of Record online : 30 SEP 2010, DOI: 10.1111/j.1365-2893.2010.01378.x

  9. You have free access to this content
    Poster Session 4: Hepatitis B Therapy

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 1088A–1128A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27532

  10. Low efficacy of entecavir therapy in adefovir-refractory hepatitis B patients with prior lamivudine resistance

    Journal of Viral Hepatitis

    Volume 17, Issue 3, March 2010, Pages: 171–177, S. W. Cho, K. H. Koh, J. Y. Cheong, M. H. Lee, S. P. Hong, W. D. Yoo and S.-O. Kim

    Version of Record online : 12 AUG 2009, DOI: 10.1111/j.1365-2893.2009.01161.x

  11. You have free access to this content
    Entecavir resistance is rare in nucleoside naïve patients with hepatitis B

    Hepatology

    Volume 44, Issue 6, December 2006, Pages: 1656–1665, Richard J. Colonno, Ronald Rose, Carl J. Baldick, Steven Levine, Kevin Pokornowski, Cheng F. Yu, Ann Walsh, Jie Fang, Mayla Hsu, Charles Mazzucco, Betsy Eggers, Sharon Zhang, Mary Plym, Kenneth Klesczewski and Daniel J. Tenney

    Version of Record online : 28 NOV 2006, DOI: 10.1002/hep.21422

  12. Hepatitis B virus polymerase variants associated with entecavir drug resistance in treatment-naive patients

    Journal of Viral Hepatitis

    Volume 14, Issue 12, December 2007, Pages: 835–840, R. Jardi, F. Rodriguez-Frias, M. Schaper, G. Ruiz, I. Elefsiniotis, R. Esteban and M. Buti

    Version of Record online : 24 SEP 2007, DOI: 10.1111/j.1365-2893.2007.00877.x

  13. Comparison of the efficacies of entecavir 0.5 and 1.0 mg combined with adefovir in patients with chronic hepatitis B who had failed on prior nucleos(t)ide analogue treatments

    Journal of Medical Virology

    Volume 87, Issue 6, June 2015, Pages: 999–1007, Yuri Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Hyo-Suk Lee and Yoon Jun Kim

    Version of Record online : 24 FEB 2015, DOI: 10.1002/jmv.24150

  14. Antiviral efficacy of combination therapy with entecavir and adefovir for entecavir/lamivudine-resistant hepatitis B virus with or without adefovir resistance

    Journal of Medical Virology

    Volume 84, Issue 3, March 2012, Pages: 424–430, Hyo-Joon Yang, Jeong-Hoon Lee, Yoon Jun Kim, Jung-Hwan Yoon and Hyo-Suk Lee

    Version of Record online : 13 JAN 2012, DOI: 10.1002/jmv.23229

  15. Entecavir plus adefovir versus adefovir plus lamivudine in hepatitis B virus e antigen-positive, lamivudine-resistant chronic hepatitis B

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 7, July 2014, Pages: 1485–1493, Jeong Heo, Sang Hoon Ahn, Young-Oh Kweon, Byung-Ho Kim, Henry L Y Chan, Andrzej Horban, Suchat Wongcharatrawee, Cyril Llamoso and Kwan Sik Lee

    Version of Record online : 15 JUL 2014, DOI: 10.1111/jgh.12567

  16. Evaluation of HBV DNA decay kinetics in patients containing both rtM204V/I mutant and wild-type HBV subpopulations during tenofovir DF (TDF) monotherapy or combination therapy with emtricitabine (FTC)/TDF

    Journal of Medical Virology

    Volume 86, Issue 9, September 2014, Pages: 1473–1481, Yang Liu, Scott Fung, Edward J. Gane, Phillip Dinh, John F. Flaherty, Evguenia S. Svarovskaia, Michael D. Miller and Kathryn M. Kitrinos

    Version of Record online : 23 MAY 2014, DOI: 10.1002/jmv.23982

  17. Hepatitis B virus drug resistance to current nucleos(t)ide analogs: Mechanisms and mutation sites

    Hepatology Research

    Volume 41, Issue 11, November 2011, Pages: 1017–1024, Lihui Deng and Hong Tang

    Version of Record online : 15 SEP 2011, DOI: 10.1111/j.1872-034X.2011.00873.x

  18. You have free access to this content
    Poster Session 3: Hepatitis B: Virology, Immunology, and Pathogenesis; Pediatric Liver Disease

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 1001A–1056A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28234

  19. Adefovir-based combination therapy with entecavir or lamivudine for patients with entecavir-refractory chronic hepatitis B

    Journal of Medical Virology

    Volume 84, Issue 1, January 2012, Pages: 18–25, Soon Sun Kim, Jae Youn Cheong, Dami Lee, Myoung Hee Lee, Sun Pyo Hong, Soo-Ok Kim and Sung Won Cho

    Version of Record online : 25 OCT 2011, DOI: 10.1002/jmv.22227

  20. You have free access to this content
    Randomized trial of lamivudine versus entecavir in entecavir-treated patients with undetectable hepatitis B virus DNA: Outcome at 2 Years

    Hepatology

    Volume 53, Issue 4, April 2011, Pages: 1148–1153, James Fung, Ching-Lung Lai, John Yuen, Charles Cheng, Ringo Wu, Danny Ka-Ho Wong, Wai-Kay Seto, Ivan Fan-Ngai Hung and Man-Fung Yuen

    Version of Record online : 7 APR 2011, DOI: 10.1002/hep.24192